Your shopping cart is currently empty

Adenosine receptor antagonist5 (Compound 39) serves as a selective antagonist for the human adenosine A3 receptor (hA3R) with a Ki of 12 nM. This compound inhibits the accumulation of IB-MECA-induced cAMP in NCI-H1792 cells and suppresses the proliferation of LK-2 and NCI-H1792 cancer cells. Additionally, Adenosine receptor antagonist5 exhibits a rapid metabolism rate in human liver microsomes.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Adenosine receptor antagonist5 (Compound 39) serves as a selective antagonist for the human adenosine A3 receptor (hA3R) with a Ki of 12 nM. This compound inhibits the accumulation of IB-MECA-induced cAMP in NCI-H1792 cells and suppresses the proliferation of LK-2 and NCI-H1792 cancer cells. Additionally, Adenosine receptor antagonist5 exhibits a rapid metabolism rate in human liver microsomes. |
| Targets&IC50 | A3 (human):12 nM (Ki) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.